Conclusion The GLP-1RA medication class is widely used and has growing clinical indications based on excellent clinical outcomes
Retatrutide reduces thirst perception while GI symptoms can cause fluid loss
The New England Journal of Medicine, 389 (24), 22212232
Whilst transdermal patch formulations represent an area of ongoing pharmaceutical research, no GLP-1 patches are currently licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) or approved by the National Institute for Health and Care Excellence (NICE) for use in the United Kingdom
In April, GNC launched a section devoted to nutritional support for GLP-1 users in each of its 2,300-plus stores, with Supergut as the anchor brand
Ilene Ruhoy joined the Bendy Bodies Podcast (Episode 132) to discuss this topic, and were also breaking down exciting new research findings